The emergence of SARS-CoV-2 as a novel infection poses unique healthcare systems and practitioners’ unique challenges. Chief among them is the management for pregnant women who are infected with SARS-CoV-2. Pregnant women are prone to a range of fetal and maternal complications that could impact any concurrent infection outcome.
The emergence of SARS-CoV-2 and its rapid spread raised concerns regarding its effects on pregnancy outcomes. We reviewed 245 pregnancies complicated by maternal SARS-CoV-2 infection. The most common clinical presentations were fever, cough, fatigue, and dyspnea.
Of all patients, 89.0% delivered via cesarean section, with a 33.3% rate of gestational complications, a 35.3% rate of preterm delivery, and a concerning 2.5% rate of stillbirth delivery neonatal death. Among those tested, 6.45% of newborns were reported positive for SARS-CoV-2 infection.
The study concluded that relative to known viral infections, the prognosis for pregnant women with SARS-CoV-2 is right, even in the absence of specific antiviral treatment. However, neonates and acute patients, especially those with gestational or preexisting comorbidities, must be actively managed to prevent the severe outcomes from being increasingly reported in the literature.